C. Brumm

The significance of alpha‐fetoprotein and other tumour markers in differential immunocytochemistry of primary liver tumours

C. Brumm, Cornelia Schulze, Karina Charels et al. · Histopathology · 1989 · 97 citations

Medicine, Oncology, Pathology +17

Hormone Replacement Therapy after Treatment of Breast Cancer: Effects on Postmenopausal Symptoms, Bone Mineral Density and Recurrence Rates

Matthias W. Beckmann, D. Jap, S. Djahansouzi et al. · Oncology · 2001 · 60 citations

Medicine, Endocrinology, Oncology +17

Immunohistochemical investigation and Northern blot analysis of c-erbB-2 expression in normal, premalignant and malignant tissues of the corpus and cervix uteri

C. Brumm, A. Riviére, C Wilckens et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 1990 · 49 citations

Medicine, Oncology, Pathology +17

Usefulness of Immunohistochemical Staining for p53 in the Prognosis of Breast Carcinomas: Correlations with Established Prognosis Parameters and with the Proliferation Marker, MIB-1

Thomas Beck, E Weller, W. Weikel et al. · Gynecologic Oncology · 1995 · 45 citations

Medicine, Oncology, Pathology +17

Immunohistochemical Detection of Hormone Receptors in Breast Carcinomas (ER-ICA, PgR-ICA): Prognostic Usefulness and Comparison with the Biochemical Radioactive-Ligand-Binding Assay (DCC)

Thomas Beck, W. Weikel, C. Brumm et al. · Gynecologic Oncology · 1994 · 44 citations

Medicine, Endocrinology, Oncology +17